A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel

Clinical Infectious Diseases

Volumn 35, Issue 3, 2002, Pages 261-267

  Wortmann, Glenn ^a,b   Miller, R Scott ^a,b   Oster, Charles ^a,b   Jackson, Joan ^c   Aronson, Naomi ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b University of Health Sciences   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; STIBOGLUCONATE SODIUM; TRIACYLGLYCEROL LIPASE;

AGED; AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INTERMETHOD COMPARISON; LEISHMANIA; MYALGIA; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; SKIN LEISHMANIASIS; SOLDIER; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UNITED STATES;

ADULT; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; ARTHRALGIA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; MILITARY PERSONNEL; PANCREATITIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0036680460     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/341406     Document Type: Article

References (15)

1. Clinical spectrum of leishmaniasis
2. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies
3. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies
4. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: Recent US military experience
5. Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-γ in treating cutaneous leishmaniasis in Guatemala
6. Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species
7. Characterization of Leishmania spp by isoenzyme electrophoresis
8. Biochemical identities and differences among Leishmania species and subspecies
9. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis
10. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis
11. Placebo-controlled clinical trial of meglumine antimonate (Glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala
12. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala
13. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate
14. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: Controlled study
15. Drug resistance in leishmaniasis: Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease